Clinical TrialID 297

The Efficacy of Jobelyn (Sorghum Bicolor Extract)in the Treatment of Sickle Cell Anemia

NCT01703104

Sickle Cell Anemia

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Herb: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
297
Evidence Id
297
Core Evidence Id
297
Source Clinical Trial Id
283
Herb2 Clinical Trial Id
HBCT000283
Nct Id
NCT01703104
Title
The Efficacy of Jobelyn (Sorghum Bicolor Extract)in the Treatment of Sickle Cell Anemia
Status
Completed
Phase
Phase 1|Phase 2
Study Result
No
Study Condition
Sickle Cell Anemia
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (CARE_PROVIDER)|Primary Purpose: TREATMENT
Intervention
DRUG: Paludrine + Folic Acid|DIETARY_SUPPLEMENT: Paludrine + Folic Acid + Jobelyn
Intervention Allocation
Randomized
Intervention Model
Crossover
Intervention Mask
Single
Intervention Purpose
Treatment
Gender
All
Age
Child, Adult
Enrollment
150
Outcome Measure
Number of Participants with Adverse Events, The number of participants who reported with Adverse events for the 12-week duration of the study, 12 weeks
Sponsor Collaborator
Lagos State University
Funded By
OTHER
Location
Lagos State University Teaching Hospital, Ikeja, Lagos, 100001, Nigeria
Other Id
LASUTH/SCD02/2012
Start Date
2012-01
Primary Completion Date
2012-03
Completion Date
2012-08
First Posted
2012-10-10
Results First Posted
Last Update Posted
2012-10-10
Study Document
Study Url
https://clinicaltrials.gov/study/NCT01703104
Title Cn
Title En
The Efficacy of Jobelyn (Sorghum Bicolor Extract)in the Treatment of Sickle Cell Anemia
Bilingual Status
semi_complete